High discontinuation rates of GLP-1 agonists found among patients with obesity

Discontinuation of GLP-1 receptor agonists in obesity is common, driven by weight regain and socioeconomic factors, impacting treatment effectiveness.

Tune Therapeutics unveils potentially curative approach to treating chronic HBV infection

Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection.

November 20, 2023

Federal officials step down from health AI group’s board

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Two federal government officials have stepped down

July 10, 2024

Psilocybin promotes lasting belief change by altering neural entropy

Psilocybin significantly reduces confidence in negative self-beliefs four weeks after administration, with effects linked to unitive experiences and neural entropy, suggesting a potential pathway for

January 31, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.